Key result
High-dose aspirin consumption was associated with a marginal reduction in pancreatic cancer risk, while low-dose aspirin showed no preventive effect.
Why the study?
Does high-dose aspirin consumption reduce the risk for pancreatic cancer?
Meta-Analysis (n=127,252)
Does high-dose aspirin consumption reduce the risk for pancreatic cancer?
Answers are grounded in this paper and cite their sources.
High-dose aspirin may offer chemoprevention against pancreatic cancer.
Article High-dose Aspirin Consumption Contributes to Decreased Risk for Pancreatic Cancer in a Systematic Review and Meta-analysis
No takes yet. Share an insight, caveat, or question.
Kim et al. (2014) conducted a meta-analysis in Pancreatic cancer (n=127,252). High-dose aspirin vs. Non-users or low-dose was evaluated on Risk of pancreatic cancer (OR 0.88, 95% CI 0.76-1.01, p=0.069). High-dose aspirin consumption was associated with a marginal reduction in pancreatic cancer risk, while low-dose aspirin showed no preventive effect.
Synapse has enriched 10 related papers. Consider them for comparative context: